Daniel Jamieson is the CEO and Founder of Biorelate, a biomedical curation company that aims to accelerate insights and innovation in future drug discovery. Daniel started Biorelate in the midst of a computational biology PhD at the University of Manchester after the successful identification of drug repurposing opportunities with Pfizer. He is now coming up to 7 years into that journey, and his focus remains on turning Biorelate into a world-leading enterprise, helping pioneering companies and researchers in their mission to develop life-saving innovations.